OKOMERA is seeking a highly-motivated assistant engineer to work on fluidic R&D projects and to produce our microfluidic chips that are the very core of OKOMERA’s technology and know-how. These chips will besold to our first clients in early 2022. The microfluidics assistant engineer will be responsible for the chip quality control and will actively participate in the optimization of all the related processes. On the R&Dside, her/he will perform the microfluidic experiments required to optimize chip design and fluidic protocols. Therefore, she/he will be largely involved in the R&D discussions. The microfluidics assistant engineer will be working under the direct supervision of the microfluidic engineer. Details of missions will varydepending on the level of expertise of the recruited profile.
Requirements
Bachelor of science or equivalent (Bac+2/+3: BTS/DUT/Licence) in laboratory work
Great experimental and practical skills
Great organization and great autonomy
Great reporting skills
Ability to work in English within an international team
Ideal candidates may have
2+ years of industrial experience in R&D projects
Skills in microscopy
Previous experience in microfabrication or in microfluidics would be a real plus
Contract : CDI
Starting Date : from February 2022
Salary : based on experience
Education Level : Bachelor of Science, License, DUT or BTS
Location : Paris, Brain Institute (ICM), Hôpital Pitié-Salpêtrière
About Okomera and Microfluidics for clinical oncology
OKOMERA is a newly created start-up (2020) spun out from Ecole Polytechnique and Institut Pasteur, whose key mission is to help selecting the best treatment for each cancer patient. OKOMERA is currently codeveloping functional ex vivo assays with our clients, key opinion leaders leading research inprecision cancer medicine.
OKOMERA clients currently use our 3D cell culture microfluidic technology [1] to cultivate primary patient cells from tumor biopsies, and/or cell lines, to assess cell functionalities(drug sensitivity, morphology, migration). OKOMERA’s droplet array technology enables to automate the formation of complex 3D cell cultures (micro-tumors with co-cultures, hydrogels), and to test tens to hundreds of individual conditions on a single chip [2]. OKOMERA prides itself on supplying easy-to-use products (fluidic machine, chips and software) built for non-experts who wish to automate high-throughput 3D sample testing.
OKOMERA was awarded the national iLAB prize from BPI France in 2019, the COMET program from WILCO, iscurrently incubated at Hôpital Pitié Salpêtrière in Paris and recently finalized its initial funding round. We are currently a team of 7, and are actively hiring to grow and deliver our alpha solution to our first clients in early 2022.
1- Sart, R. F.-X. Tomasi, G. Amselem, and C. N. Baroud, “Multiscale cytometry and regulation of 3D cellcultures on a chip,” Nat. Commun., vol. 8, p. 469, 2017.
2- F. X. Tomasi, S. Sart, T. Champetier, and C. N. Baroud, “Individual Control and Quantification of 3DSpheroids in a High-Density Microfluidic Droplet Array,” Cell Rep., vol. 31, no. 8, 2020.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
